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Unilateral nevoid telangiectasia (UNT) is a rare disease 
characterized by punctuate and stellate telangiectasias that 
follow dermatomal distribution.1 Its etiology remains elu-
sive; no standard treatment currently exists. We describe 
a 14-year-old Asian female (skin type IV) with UNT, who 
underwent treatment with long-pulsed 1064-nm Nd:YAG 
laser and 595-nm pulsed dye laser for her disease.
The patient came to our clinic with linearly arranged, 
punctate telangiectasias over right side of back, shoulder, 
and arm (Figure 1). The lesions appeared at the age of 10. 
The diagnosis of UNT was made based on the clinical man-
ifestations and telangiectasias in superficial dermis (as shown 
on a histologic exam done previously at another hospital). 
Angioma serpiginosum is an important differential diagnosis 
of UNT in this case.
Three sessions of treatment with long-pulsed 1064-nm 
Nd:YAG laser (GentleYAG Laser; Candela Laser, Wayland, 
MA, USA) were given with parameters (fluence-spot size-
pulse width) of 240 J/cm2-3 mm-10 ms (first week), 240 J/
cm2-3 mm-10 ms (second week), and 280 J/cm2-3 mm-10 ms 
(third week). The interval between each session was 4 weeks. 
However, there was only slight improvement. Histologic 
exam performed 2 weeks after the third session revealed 
marked telangiectasias in papillary dermis (Figure 2).
Next, two sessions of pulsed dye laser with 595 nm 
wavelength (Vbeam Perfecta; Candela Laser) were given 
with parameters of 13 J/cm2-7 mm-40 ms (fluence-spot size-
pulse width) for both sessions. Significant lightening of 
lesions (> 90%) was observed after the second session 
(Figure 3). The only adverse reaction was transient purpura 
that lasted for approximately 2 weeks. There was no hypo- 
or hyper-pigmentation after treatment.
There are two forms of UNT, the rarer congenital form and 
the more common acquired form.2 Telangiectasia develops 
during puberty in most of the acquired cases, as in our pa-
tient. Several reports point out the systemic association of 
acquired UNT, such as hyperestrogenemia and chronic 
liver disease.2 In out patient, there was no evidence of high 
serum level of estrogen or hepatic disease.
Both long-pulsed 1064-nm Nd:YAG laser and pulsed dye 
laser have been shown to be effective in treating vascular 
lesions.3,4 Major et al3 reported good response with the 
former for facial and leg telangiectasias. However, it does 
not seem to be a good treatment modality for UNT for the 
current case. One possible explanation is that while the 
1064-nm Nd:YAG laser beam tends to penetrate to deeper 
dermis, due to its long wavelength and lesser absorption 
Figure 1 Clinical picture before treatment.
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least four sessions of treatment. Five of the six patients had 
hypo- or hyper-pigmentation after treatment.
In our patient, the 595-nm pulsed dye laser was employed; 
the fluence was higher and pulse width longer, which could 
potentially have produced a slower and more thorough 
vessel heating with decreased post-treatment purpura for-
mation.5 The response was significant; more than 75% light-
ening was achieved after the first session, and more than 90% 
after the second. In addition, there was no post-treatment 
hypo- or hyper-pigmentation. Our patient had comparable 
skin type with the Sharma et al2 patients. However, the rea-
son behind the significant pigment change after treatment 
in their patients but not ours remains unknown. While their 
patients were treated with lower fluence and shorter pulse 
width, racial difference might also have had an effect on 
treatment outcome.
In conclusion, according to our experience with the cur-
rent patient, the 595-nm pulsed dye laser is a useful mo-
dality of treatment for unilateral nevoid telangiectasia. The 
long-pulsed 1064 nm Nd:YAG laser may not be the treat-
ment of choice for unilateral nevoid telangiectasia owing to 
its poorer absorption by oxyhemoglobin.
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by superficial chromophores, the telangiectasias of UNT 
occur in superficial dermis. In addition, the 1064-nm laser 
beam is better absorbed by deoxyhemoglobin,3 which is 
more abundant in deep-seated larger veins rather than in 
small dilated vessels noted in UNT.
The pulsed dye laser has been shown to have great vascu-
lar specificity and clinical effectiveness.5 For UNT, Sharma 
et al2 reported good response while using 585-nm pulsed 
dye laser in 6 cases (skin types III and IV). The parameters 
were of 5–7.5 J/cm2-7 mm-0.45 ms (fluence-spot size-pulse 
width). Three patients (50% of cases) achieved more than 
75% lightening of lesions. Among them, two needed at 
Figure 2 Histologic exam showing marked telangiectasia in superfi-
cial dermis (H&E, 100×).
Figure 3 Clinical picture after the second session of dye laser. The 
two spots of hyperpigmentation over right scapula resulted from skin 
biopsy.
